The impact of a person-centred community pharmacy mental health medication support service on consumer outcomes
© 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. Background: Mental illness is a worldwide health priority. As medication is commonly used to treat mental illness, community pharmacy staff is well placed to assist consumers. Aim: To evaluate the effecti...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Informa Healthcare
2017
|
| Online Access: | http://hdl.handle.net/20.500.11937/55474 |
| _version_ | 1848759631215591424 |
|---|---|
| author | McMillan, S. Kelly, F. Hattingh, H. Laetitia Fowler, J. Mihala, G. Wheeler, A. |
| author_facet | McMillan, S. Kelly, F. Hattingh, H. Laetitia Fowler, J. Mihala, G. Wheeler, A. |
| author_sort | McMillan, S. |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. Background: Mental illness is a worldwide health priority. As medication is commonly used to treat mental illness, community pharmacy staff is well placed to assist consumers. Aim: To evaluate the effectiveness of a multifaceted, community pharmacy medication support service for mental health consumers. Method: Pharmacists and pharmacy support staff in three Australian states were trained to deliver a flexible, goal-oriented medication support service for adults with mental illness over 3–6 months. Consumer-related outcome measures included perceptions of illness and health-related quality of life, medication beliefs, treatment satisfaction and medication adherence. Results: Fifty-five of 100 trained pharmacies completed the intervention with 295 of the 418 recruited consumers (70.6% completion rate); 51.2% of consumers received two or more follow-ups. Significant improvements were reported by consumers for overall perceptions of illness (p? < ?0.001), the mental health domain of quality of life (p? < ?0.001), concerns about medication (p?=?0.001) and global satisfaction with medication (p? < ?0.001). Consumers also reported an increase in medication adherence (p?=?0.005). Conclusions: A community pharmacy mental health medication support service that is goal-oriented, flexible and individualised, improved consumer outcomes across various measures. While further research into the cost-effectiveness and sustainability of such a service is warranted, this intervention could easily be adapted to other contexts. |
| first_indexed | 2025-11-14T10:02:57Z |
| format | Journal Article |
| id | curtin-20.500.11937-55474 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T10:02:57Z |
| publishDate | 2017 |
| publisher | Informa Healthcare |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-554742017-09-13T16:10:06Z The impact of a person-centred community pharmacy mental health medication support service on consumer outcomes McMillan, S. Kelly, F. Hattingh, H. Laetitia Fowler, J. Mihala, G. Wheeler, A. © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. Background: Mental illness is a worldwide health priority. As medication is commonly used to treat mental illness, community pharmacy staff is well placed to assist consumers. Aim: To evaluate the effectiveness of a multifaceted, community pharmacy medication support service for mental health consumers. Method: Pharmacists and pharmacy support staff in three Australian states were trained to deliver a flexible, goal-oriented medication support service for adults with mental illness over 3–6 months. Consumer-related outcome measures included perceptions of illness and health-related quality of life, medication beliefs, treatment satisfaction and medication adherence. Results: Fifty-five of 100 trained pharmacies completed the intervention with 295 of the 418 recruited consumers (70.6% completion rate); 51.2% of consumers received two or more follow-ups. Significant improvements were reported by consumers for overall perceptions of illness (p? < ?0.001), the mental health domain of quality of life (p? < ?0.001), concerns about medication (p?=?0.001) and global satisfaction with medication (p? < ?0.001). Consumers also reported an increase in medication adherence (p?=?0.005). Conclusions: A community pharmacy mental health medication support service that is goal-oriented, flexible and individualised, improved consumer outcomes across various measures. While further research into the cost-effectiveness and sustainability of such a service is warranted, this intervention could easily be adapted to other contexts. 2017 Journal Article http://hdl.handle.net/20.500.11937/55474 10.1080/09638237.2017.1340618 Informa Healthcare unknown |
| spellingShingle | McMillan, S. Kelly, F. Hattingh, H. Laetitia Fowler, J. Mihala, G. Wheeler, A. The impact of a person-centred community pharmacy mental health medication support service on consumer outcomes |
| title | The impact of a person-centred community pharmacy mental health medication support service on consumer outcomes |
| title_full | The impact of a person-centred community pharmacy mental health medication support service on consumer outcomes |
| title_fullStr | The impact of a person-centred community pharmacy mental health medication support service on consumer outcomes |
| title_full_unstemmed | The impact of a person-centred community pharmacy mental health medication support service on consumer outcomes |
| title_short | The impact of a person-centred community pharmacy mental health medication support service on consumer outcomes |
| title_sort | impact of a person-centred community pharmacy mental health medication support service on consumer outcomes |
| url | http://hdl.handle.net/20.500.11937/55474 |